The Patents (Amendment) (EU Exit) Regulations 2019

• Citation: S.I. 2019/801
• Sections: 69

Section 1

These Regulations may be cited as the Patents (Amendment) (EU Exit) Regulations 2019 and come into force on exit day.

Section 2

The Patents Act 1977 is amended follows.

Section 3

In section 128A (EU compulsory licences)—

(a) in the heading for “EU compulsory”, substitute “Compulsory pharmaceutical”;

(b) in subsection (1), for “an “EU compulsory”, substitute “a “compulsory pharmaceutical”;

(c) in subsection (2)—

(i) for “EU compulsory”, substitute “ compulsory pharmaceutical ” ;

(ii) “an EU compulsory”, substitute “a compulsory pharmaceutical”;

(d) in subsection (5), for “an EU compulsory”, substitute “ a compulsory pharmaceutical ” .

Section 4

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Section 5

(1) Section 281 (power of comptroller to refuse to deal with certain agents) of the Copyright, Designs and Patents Act 1988 is amended as follows.

(2) In subsection (5), for the words from the words “another” to the end, substitute “ a member State ” .

Section 6

The Patents and Plant Variety Rights (Compulsory Licensing) Regulations 2002 are amended as set out in this Part.

Section 7

(1) Regulation 2 (interpretation) is amended as follows.

(2) In paragraph (1)—

(a) omit the definition of “Community plant variety right”;

(b) omit the definition of “Council Regulation”;

(c) for the definition of “plant breeders' rights”, substitute—

“plant breeders’ right” means—

any right granted under, or having effect as if granted under, section 3 of the 1997 Act (including existing rights as defined by section 40(4) of that Act); and

any right which by virtue of regulation 3 of the Plant Breeders’ Rights (Amendment etc.) (EU Exit) Regulations 2019 is treated as if it were a plant breeders’ right granted in accordance with the 1997 Act and as if the variety were registered in accordance with regulations under section 18(1)(c) of the 1997 Act;

Section 8

(1) Regulations 3 (applications) and 6 (grant) are amended as follows.

(2) Omit “or a Community plant variety right” and “or Community plant variety right” wherever they occur.

Section 9

In regulation 7 (conditions), omit paragraphs (4) and (5).

Section 10

Omit regulation 15 (Community plant variety rights.).

Section 11

In regulation 16 (variation and revocation), omit paragraphs (4) to (7).

Section 12

In regulation 17, for paragraph (2), substitute—

(2) Where a decision of the controllers relates to a compulsory patent licence or cross licence ordered to be granted under regulation 7(2) or 7(3), an appeal may be made to the court.

Section 13

(1) Regulation 20 (extension of powers to make rules and regulations) is amended as follows.

(2) In paragraph (a), for “regulations 3(1) and 15(1)”, substitute “ regulation 3(1) ” .

(3) In paragraph (b)—

(a) for “regulations 8 and 16(4)” substitute “ regulation 8 ” ; and

(b) for “regulations 9 and 16(5)”, substitute “ regulation 9 ” .

Section 14

(1) Regulation 22 (application of existing rules and regulations) is amended as follows.

(2) In paragraph (1), for “regulations 7(2), 7(3) and 15(3)”, substitute “ regulation 7(2) and 7(3) ” .

(3) In paragraph (2), for “other than in relation to an application under regulation 15(1), and with any other necessary modifications”, substitute “ with any necessary modifications ” .

Section 15

In regulation 24, omit “or 15(1)”.

Section 16

(1) Regulation 26 (application of 1977 and 1997 Acts) is amended as follows.

(2) In paragraph (1), in both places where it occurs, for “regulations 7(2), 7(3) and 15(3)”, substitute “ regulation 7(2) and 7(3) ” .

(3) In paragraph (3), for “regulations 15(1), 16(3) and 16(4)” substitute “ regulation 16(3) ” .

Section 17 Transitional provision

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Section 18

(1) The Patents Rules 2007 are amended as follows.

(2) In rule 85(1), omit from “, but not resident” to “the Civil Jurisdiction and Judgements Act 1982”.

(3) In rule 103(4), for “another EEA state”, substitute “ an EEA state ” .

(4) In Part 1 of Schedule 3—

(a) in the entry relating to Article 5(c) of the Compulsory Licensing Regulation, for “EU compulsory”, substitute “ compulsory pharmaceutical ” ; and

(b) in the entries relating to Articles 6(1), 16(1) and 16(4), for “an EU compulsory”, substitute “ a compulsory pharmaceutical ” .

Section 19

Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products is amended as set out in this Part.

Section 20

(1) Article 1 (definitions) is amended as follows.

(2) In paragraph 1(c), omit “Council or Commission”.

(3) After paragraph 10, insert—

(11) ‘comptroller’ means the Comptroller-General of Patents, Designs and Trade Marks;

(12) ‘court’ means—

(a) as respects England and Wales, the High Court;

(b) as respects Scotland, the Court of Session;

(c) as respects Northern Ireland, the High Court in Northern Ireland ;

(13) ‘EEA authorization’ means an authorization to place a plant protection product on the market which has effect in an EEA state in accordance with Regulation (EC) No 1107/2009 ;

(14) ‘patent’ means a patent which has effect in the United Kingdom;

(15) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Section 21

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Section 22

For Article 2, substitute—

Scope

A plant protection product may, under the terms and conditions provided for in this Regulation, be the subject of a certificate if it is—

(a) protected by a patent; and

(b) the subject of a GB or NI authorization prior to being placed on the market as a plant protection product.

Section 23

For Article 3(1), substitute—

(1) Where an application is submitted under Article 7, a certificate shall be granted if at the date of submission of the application—

(a) the product is protected by a basic patent in force;

(b) there is a valid GB or NI authorization to place the product on the market;

(c) the product has not already been the subject of a certificate;

(d) the authorization referred to in (b) is the first ... authorization to place the product on the market as a plant protection product in the territory of England and Wales and Scotland or the territory of Northern Ireland as the case may be .

Section 24

(1) Article 8 (contents of the application for a certificate) is amended as follows.

(2) For paragraph 1(a)(iv), substitute—

(iv) the number and date of the GB or NI authorisation or both GB and NI authorisations as referred to in Article 3(1)(b) and (d) ; and

(v) the number and date of the earliest EEA authorization, the granting of which predates the granting of the GB or NI authorization as referred to in Article 3(1)(b) and (d) ;

(3) For paragraph 8(1)(b) and (c), substitute—

(b) a copy of the GB or NI authorisation or both GB and NI authorisations to place the product on the market, as referred to in Article 3(1)(b) and (d) , in which the product is identified, containing in particular the number and date of the authorization and the summary of the product characteristics listed in Commission Regulation 283/2013, Part A section 1, points 1.1 to 1.7 or Part B, Section 1 points 1.1 to 1.4.3 ;

(c) where the product is the subject of one or more EEA authorizations granted prior to the GB or NI authorization referred to in Article 3(1)(b) and (d) , the applicant must provide in relation to the earliest of any such EEA authorizations—

(i) information regarding the identity of the product thus authorised;

(ii) information regarding the legal provision under which the authorization procedure took place; and

(iii) a copy of the notice publishing the authorization in the appropriate official publication or, failing such a notice, any other document proving that the authorization has been issued, the date on which it was issued and the identity of the product authorized.

(4) Omit paragraph 2.

Section 25

(1) Article 9 (lodging of an application for a certificate) is amended as follows.

(2) For paragraph 1, substitute—

(1) An application for a certificate shall be lodged with the comptroller.

(3) In the introductory words of paragraph 2, for “authority referred to in paragraph 1” substitute “ comptroller ” .

(4) For sub-paragraphs (d) and (e) of paragraph 2, substitute—

(d) the number and date of the GB or NI authorisation or both a GB and a NI authorisation provided under Article 8(1)(b), the product identified in the authorisation and the territory in respect of which the authorisation has been granted or has effect as if granted;

(e) where there are EEA authorizations granted before any GB or NI authorisation provided under Article 8(1)(b) , the number and date of the earliest EEA authorization;

Section 26

(1) Article 10 (grant of the certificate or rejection of the application) is amended as follows.

(2) In paragraphs 1 to 3, for “the authority referred to in Article 9(1)”, substitute “ the comptroller ” .

(3) In paragraph 2, after “in this Regulation”, insert “ or any prescribed fee is not paid ” .

(4) In paragraph 3, after “Article 8”, insert “ or the prescribed fee relating to the application has not been paid ” .

(5) Omit paragraph 5.

(6) At the end of the Article, insert—

(6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Section 27

(1) Article 11 (publication) is amended as follows.

(2) In paragraphs 1 and 2, for “the authority referred to in Article 9(1)” substitute “ the comptroller ” .

(3) In paragraph 1—

(a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(b) for sub-paragraph (e), substitute—

(e) where there are EEA authorizations granted before any authorisation provided under Article 8(1)(b) , the number and date of the earliest EEA authorization;

Section 28

Omit Article 12 (annual fees).

Section 29

In paragraph 1 of Article 13 (duration of the certificate), for “the Community”, substitute “ the area comprising the European Economic Area and the United Kingdom ” .

Section 30

(1) Article 14 (expiry of the certificate) is amended as follows.

(2) The existing text is numbered as paragraph 1.

(3) For sub-paragraphs (c) and (d) of the renumbered paragraph 1, substitute—

(c) if the prescribed annual fee is not paid in time; or

(d) if and as long as the product covered by the certificate may no longer be placed on the market following the withdrawal of all authorizations to place on the market in accordance with Article 28 of Regulation 1107/2009. The comptroller may decide on the lapse of the certificate either of the comptroller's own motion or at the request of a third party.

(4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Section 31

In paragraph (2) of Article 15 (invalidity of certificate), for “the body responsible under national law for the revocation of the corresponding basic patent” substitute “ the comptroller or the court ” .

Section 32

In Article 16 (notification of lapse or invalidity), for “the authority referred to in Article 9(1)”, substitute “ the comptroller ” .

Section 33

In Article 17 (appeals), omit paragraph 1.

Section 34

In Article 18 (procedure), for paragraph 1 substitute—

(1) In the absence of procedural provisions in this Regulation, the procedural provisions applicable to the corresponding basic patent (as modified by section 128B of, and Schedule 4A to, the Patents Act 1977) shall apply to the certificate.

Section 35

Omit Articles 19 and 20 (transitional provisions).

Section 36

After Article 21 (entry into force), omit “This Regulation shall be binding in its entirety and directly applicable in all Member States.”.

Section 37

Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems is amended as set out in this Part.

Section 38

(1) Article 1 (scope) is amended as follows.

(2) For “Member States”, substitute “ The competent authority ” .

Section 39

(1) Article 2 (definitions) is amended as follows.

(2) For the definition of “competent authority” in paragraph (4), substitute—

“ competent authority ” for the purposes of Articles 1 to 11, 16 and 17 means the Comptroller-General of Patents, Designs and Trade Marks;

(3) After paragraph (4), insert—

(5) “ patent ” means “a patent under the Patents Act 1977;

(6) “ supplementary protection certificate ” means a supplementary protection certificate issued under Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products

(4) Omit Article 3 (competent authority).

Section 40

In Article 4 (eligible importing countries), for “Commission”, substitute “ United Kingdom ” .

Section 41

(1) Article 5 (extension to least-developed and developing countries which are not members of the WTO) is amended as follows.

(2) In paragraph (a), for “Commission”, substitute “ Secretary of State ” .

(3) In paragraph (c), omit “or on its own initiative if national law allows the competent authority to act on its own initiative,”.

Section 42

(1) Article 6 (application for a compulsory licence) is amended as follows.

(2) For paragraph 1, substitute—

(1) Any person may submit an application for a compulsory licence under this Regulation to the competent authority in a case where that person's intended activities of manufacture and sale for export are covered by a patent or a supplementary protection certificate.

(3) In paragraph 2, for “each application”, substitute “ the application made to the competent authority ” .

(4) Omit paragraph 4.

Section 43

In Article 8 (verification), for “Commission”, wherever it occurs, substitute “ United Kingdom ” .

Section 44

(1) Article 10 (compulsory licence conditions) is amended as follows.

(2) In paragraph 5, for “Member States”, substitute “ United Kingdom ” .

(3) In paragraph 8, omit “or on its own initiative, if national law allows the competent authority to act on its own initiative.”.

Section 45

(1) Article 12 (notification) is amended as follows.

(2) For “Member State”, substitute “ Secretary of State ” .

(3) Omit “through the intermediary of the Commission”.

Section 46

In Article 13 (prohibition of importation), in paragraph 1, for “Community”, substitute “ United Kingdom ” .

Section 47

(1) Article 14 (action by customs authorities) is amended as follows.

(2) In paragraph 1—

(a) for “Community” substitute “ United Kingdom ” ; and

(b) omit “Member States shall ensure that a body has the authority to review whether such importation is taking place”.

(3) In paragraph 2, for “national provisions on”, substitute “ the law relating to ” .

(4) In paragraph 3, for “Community”, substitute “ United Kingdom ” .

(5) In paragraph 4, omit “, in accordance with national legislation,”.

(6) Omit paragraph 6.

Section 48

(1) Article 16 (termination or review of the licence) is amended as follows.

(2) In paragraph 2, for “through the intermediary of the Commission”, substitute “ by the Secretary of State ” .

(3) In paragraph 3, omit—

(a) “or any other body appointed by the Member State”; and

(b) “or by another body appointed by the Member State,”.

Section 49

Omit Articles 17 to 19. (appeals, safety and efficacy of medicinal products and review)

Section 50

After Article 20 (entry into force), omit “This Regulation shall be binding in its entirety and directly applicable in all Member States”.